Thomopoulos Stavros, Zampiakis Emmanouil, Das Rosalina, Kim H Mike, Silva Matthew J, Havlioglu Necat, Gelberman Richard H
Department of Orthopaedic Surgery, Washington University, St. Louis, MO 63110, USA.
J Hand Surg Am. 2009 Jul-Aug;34(6):1066-73. doi: 10.1016/j.jhsa.2009.04.018.
Our previous studies in a canine animal model demonstrated that the flexor tendon-to-bone insertion site has a poor capacity to heal. Magnesium-based adhesives have the potential to improve tendon-to-bone healing. Therefore, we hypothesized that magnesium-based bone adhesive (MBA) will improve the tendon-to-bone biomechanical properties initially and in the early period after repair.
Flexor digitorum profundus tendons were injured and repaired into bone tunnels in the distal phalanges of dogs. The bone tunnels were either filled with MBA before completing the repair or left empty (control [CTL]). Histologic appearance, tensile properties, range of motion, and bone density were examined at time zero and 21 days after the repair.
There was no histologic evidence of acute inflammation. There appeared to be more mast cells in the MBA group than in the CTL group. Chronic inflammatory infiltrate and fibrosis was slightly higher in the MBA group compared with the CTL group. Tensile properties at time zero were significantly higher in the MBA group compared with the CTL group. However, tensile properties were significantly lower in the MBA group compared with the CTL group at 21 days. Range of motion and bone density were significantly lower in the MBA and CTL groups compared with normal (ie, uninjured) at 21 days; no differences were seen when comparing MBA with CTL.
We found that the initial biomechanical properties of flexor tendon-to-bone repairs can be improved with MBA. However, MBA use in vivo led to a decrease in the biomechanical properties of the repair. There was no effect of MBA on bone density or range of motion in the early period after repair. Our histologic analysis suggests that the poor healing in the MBA group may have been due to an allergic response or to increased chronic inflammation resulting from the foreign material.
我们之前在犬类动物模型中的研究表明,屈肌腱与骨的插入部位愈合能力较差。镁基粘合剂有改善肌腱与骨愈合的潜力。因此,我们假设镁基骨粘合剂(MBA)在修复初期及早期能改善肌腱与骨的生物力学性能。
在犬的远节指骨中损伤指深屈肌腱并将其修复到骨隧道中。在完成修复前,骨隧道要么用MBA填充,要么保持空的(对照组[CTL])。在修复后0天和21天检查组织学外观、拉伸性能、活动范围和骨密度。
没有急性炎症的组织学证据。MBA组的肥大细胞似乎比CTL组更多。与CTL组相比,MBA组的慢性炎症浸润和纤维化略高。修复后0天时,MBA组的拉伸性能显著高于CTL组。然而,在21天时,MBA组的拉伸性能显著低于CTL组。在21天时,MBA组和CTL组的活动范围和骨密度均显著低于正常(即未受伤)组;比较MBA组和CTL组时未发现差异。
我们发现MBA可改善屈肌腱与骨修复的初始生物力学性能。然而,在体内使用MBA会导致修复的生物力学性能下降。MBA在修复后的早期对骨密度或活动范围没有影响。我们的组织学分析表明,MBA组愈合不良可能是由于过敏反应或异物导致的慢性炎症增加。